The Bruck Pharma director, who was questioned by Mumbai police over the company’s Remdesivir stock, has denied stocking the vials in the city and claimed the consignment, has been moved to a godown in Daman, a police official said on Tuesday.
Remdesivir is listed for use in serious COVID-19 patients. In view of a sudden spike in demand for the drug due to the surge in COVID-19 cases, the Centre last week banned its export till the situation improves.
The Mumbai police on Saturday questioned Rajesh Dokania, the director of the Daman-based pharmaceutical company that manufactures Remdesivir vials, following information that around 60,000 vials were going to be flown abroad by air cargo, despite a ban on the export of the drug.
During his questioning, the police sought to know the whereabouts of the drug stock, the official said.
“The pharma company director claimed the stock was moved to the firm’s godown in the neighbouring Union Territory of Daman as its export was banned and denied stocking the vials in Mumbai,” the official said.
The police are verifying the information provided by the pharma firm executive, he said.
Surjitt Sahani
